The 14-3-3 family of proteins, recognized as central hubs in numerous cellular processes, have emerged as significant targets for pharmacological intervention, particularly in the context of diseases such as cancer, neurodegeneration, and musculoskeletal disorders. Here, YWHAQ is linked to cancer.